Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Trading Statement

16 Dec 2013 07:00

RNS Number : 5455V
Impellam Group plc
16 December 2013
 



 

 

Impellam Group plc ("Impellam" or the "Company" or "Group")

 

Pre close trading statement

 

Impellam is pleased to announce that trading during the second half of the year reflects the improving economic conditions in the Group's key markets. Our staffing businesses are all expected to see year over year growth in net fees in the second half of the year with both our UK Staffing and US Staffing business seeing full year on year growth.

 

The Group is planning to capitalise on the opportunities available in both the managed services and specialist staffing markets. Both the UK and the US Staffing businesses are keen to accelerate investment in headcount which will lead to upward cost pressure.

 

Whilst we anticipate year on year growth in operating profits in both our UK and US Staffing businesses, the costs associated with both enhanced compliance requirements and the sourcing of medical professionals is still depressing net fee conversion in our Medacs business. Accordingly, Medacs will report year on year operating profit contraction in the second half, albeit at a slower rate than we saw in the first half.

 

The Group's staffing businesses, in total, are therefore expected to see a small year on year decrease in operating profits. However, the outlook is promising with increased activity and recovering markets.

 

Trading in our Carlisle Support Services business has shown some early signs of improvement. Changes to the management structure announced at the half year are starting to deliver the benefits we anticipated in the mobilisation of high volume labour solutions to the retail, transport and logistics sectors. Whilst second half trading will not show any material improvement due to restructure costs, the outlook is more favourable. However, the business has two long term contracts, one a substantial first generation out sourcing agreement, which have proven to be operationally complex, badly priced and financially onerous. In accordance with accounting standards, full provision will be made for the costs of the exiting of one and the future ongoing losses of the other. The total provision, amounting to some £13.0 million, will be taken as an exceptional item. Having carefully reviewed the contracts portfolio, we are satisfied that no other similar contracts exist in the Group.

 

Total Group adjusted operating profit is expected to be about £5.0 million lower than the comparative period last year.

 

During the year, Impellam has returned £19.8 million to shareholders in dividends. The return of cash to shareholders remains a key objective for the Group. A final dividend of 7.0p per share will be recommended. Further details of this will be announced in due course.

 

Enquiries: For further information please contact the appropriate individual below.

 

 

Impellam Group plc

Andrew Wilson

Julia Robertson

Andrew Burchall Tel: 01582 692658

 

 

Cenkos Securities plc

(Nominated Advisor and Broker to Impellam)

Nicholas Wells Tel: 020 7397 8900

Elizabeth Bowman

 

 

Note to Editors:

 

Impellam Group plc conducts business primarily in the UK and North America, with smaller operations in Australia, Ireland, New Zealand and mainland Europe. The Group employs nearly 6,000 people, including 2,500 managers and consultants and more than 3,500 support services workers, across a network of 230 branch and regional offices. The Group operates more than 15 specialty brands across a broad range of staffing sectors which are complemented by businesses in the outsourced support services sector. Impellam Group is ranked 17th on the Staffing Industry Analysts' 2012 Top Global Staffing Companies List.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEXLFFXLFXFBF
Date   Source Headline
11th Jan 20249:03 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
10th Jan 202411:05 amRNSForm 8.3 - Impellam Group PLC
5th Jan 20242:16 pmRNSForm 8.3 - Impellam Group Plc
27th Dec 20239:02 amRNSForm 8.3 - Impellam
22nd Dec 20237:00 amRNSPublication and posting of Scheme Document
19th Dec 20239:22 amRNSForm 8.5 (EPT/RI)
19th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Dec 20231:41 pmRNSForm 8.3 - Impellam Group PLC
18th Dec 202311:03 amRNSForm 8.5 (EPT/RI)
18th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Dec 20231:00 pmRNSForm 8.3 -Impellam Group plc
15th Dec 20237:55 amRNSForm 8.5 (EPT/RI)
15th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
14th Dec 202311:09 amRNSForm 8.3 - Impellam Group plc
14th Dec 20237:31 amRNSForm 8.5 (EPT/RI)
13th Dec 20231:49 pmRNSForm 8.3 - Impellam Group plc
13th Dec 20237:00 amRNSRecommended Acquisition
12th Dec 20234:44 pmRNSExtension of PUSU Deadline
12th Dec 202311:08 amRNSForm 8.3 - Impellam Group plc
12th Dec 20237:46 amRNSForm 8.5 (EPT/RI)
12th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
11th Dec 202312:00 pmRNSForm 8.3 - Impellam Group plc
11th Dec 202310:53 amRNSForm 8.5 (EPT/RI)
11th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
8th Dec 202312:49 pmRNSForm 8.3 - Impellam Group plc
8th Dec 202310:14 amRNSForm 8.5 (EPT/RI)
7th Dec 202312:25 pmRNSForm 8.3 - Impellam Group plc
6th Dec 202312:35 pmRNSForm 8.3 - Impellam Group plc
6th Dec 202310:49 amRNSForm 8.5 (EPT/RI)
6th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
5th Dec 20234:00 pmRNSExtension of PUSU Deadline
5th Dec 20231:13 pmRNSForm 8.3 - Impellam Group plc
5th Dec 202310:29 amRNSForm 8.5 (EPT/RI)
5th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
4th Dec 202310:30 amRNSForm 8.3 - Impellam Group plc
1st Dec 202311:55 amRNSForm 8.3 - Impellam Group plc
30th Nov 202312:13 pmRNSForm 8.3 - Impellam Group plc
30th Nov 202310:45 amRNSForm 8.5 (EPT/RI)
30th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
29th Nov 20234:43 pmRNSExtension of PUSU Deadline
29th Nov 202312:04 pmRNSForm 8.3 - Impellam Group plc
29th Nov 202311:47 amRNSForm 8.5 (EPT/RI)
29th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
28th Nov 202312:09 pmRNSForm 8.3 - Impellam Group plc
28th Nov 202311:18 amRNSForm 8.5 (EPT/RI)
28th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
27th Nov 202310:45 amRNSForm 8.3 - Impellam Group Plc
24th Nov 202311:35 amRNSForm 8.3 - Impellam Group Plc
23rd Nov 202312:29 pmRNSForm 8.3 - Impellam Group plc
22nd Nov 202311:55 amRNSForm 8.3 - Impellam Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.